In detail, they show that CDK1 interacts with the small ubiquitin-like modifier (SUMO)-specific enzyme and an ubiquitin-conjugating enzyme, which in turn intervenes with the SUMO-1-modified CDK6 and contributes to cancer development and progression. Here, CDK1 is linked to cancer.